Centogene
Khuzema Hammad is a Junior Scientist at CENTOGENE, with experience in processing genetic diagnostics in the High Throughput Testing department, Sanger diagnostics, and MiSeq diagnostics. Previous roles include a Master's thesis at DKFZ German Cancer Research Center focusing on type I and III IFN receptors, and laboratory assistance at University Hospital Heidelberg, performing DNA/RNA extractions. Additional experience includes a trainee position at Friedrich Schiller University Jena and Fritz Lipmann Institute, with a Bachelor thesis addressing stem cell-based wound healing. Khuzema holds a Master's degree in Molecular Life Sciences from Friedrich Schiller University Jena and a Bachelor's degree in Biotechnology from the University of the Punjab. Active involvement in community initiatives includes serving as Information Secretary for the Pakistan Student Association in Jena.
Previous companies
This person is not in any teams
This person is not in any offices
Centogene
2 followers
Centogene BV is a Germany-based company engaged in the rare disease market. It focuses on transforming clinical, genetic and biochemical data into medical solutions for patients, physicians and pharmaceutical companies. The Company provides the full spectrum of methods and technology for human genetics analysis. It develops a rare disease platform based on its real-world data repository with over 2.0 billion weighted data points from over 450, 000 patients representing around 115 different, which includes epidemiologic, phenotypic and genetic data that reflects a global population, as well as a biobank of patients' blood samples. In addition, it is active in the research and development products for human genetics. The Company operates in Germany and the United States.